ArabFinance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) reported a 20% Year on Year decline in its net profit in the first nine months of the fiscal year (FY) 2020/2021, according to the companys May 5thunaudited financial statements filed to the Egyptian Exchange.

Net profit stood at EGP 108.172 million in July-March 2021, compared to EGP 134.371 million achieved in a corresponding period a year earlier.

The extraordinary general assembly of Alex Pharma approved the estimated budget for FY 2021/2022.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.

Copyright 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.